Population Based Prenatal Screening for the Fragile X Syndrome

Brown WT Jenkins EC . The fragile X syndrome. In: Molecular genetic medicine., Vol 2. Orlando, FL: Academic Press, 1992:39–66.

Sutherland GR . Fragile sites on human chromosomes: Demonstration of their dependence on the type of tissue culture medium. Science, 1977;197:265–6.

Lubs HA . A marker X chromosome. Am J Hum Genet, 1969;21:231–44.

Sutherland GR Hecht F Mulley JC Glover TW Hecht BK . The fragile X: Intelligence, behavior and treatment. In: Fragile sites on human chromosomes., New York: Oxford University Press, 1985:113.

Sherman SL Morton NE Jacobs PA Turner G. The marker (X) syndrome: A cytogenetic and genetic analysis. Ann Hum Genet, 1984;48:21–37.

Sherman SL Jacobs PA Morton NE Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet, 1985;69:289–99.

Kremer EJ Pritchard M Lynch M Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CGG)n. Science, 1991;252:1711–14.

Yu S Pritchard M Kremer E Fragile X genotype characterized by an unstable region of DNA. Science, 1991;252:1179–81.

Oberle I Rousseau F Heitz D Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science, 1991;252:1097–102.

Fu YH Kuhl DPA Pizzuti A Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell, 1991;67:1047–58.

Siomi H Siomi MC Nussbaum R Dreyfuss G. The protein product of the fragile X gene, FMR-1, has characteristics of an RNA binding protein. Am J Hum Genet, 1993;53:a40.

Rousseau F Hertz D Biancalana V Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med, 1991;325:1673–81.

Saiki RK Scharf S Faloona F Enzymatic amplification of β-globin genomic sequences and restriction site analysis of sickle cell anemia. Science, 1985;230:1350–4.

Eisenstein BI . The polymerase chain reaction: A new method of using molecular genetics for medical diagnosis. N Engl J Med, 1990;322:178–83.

Brown WT Houck GE Jeziorouska A Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA, 1993;270:1569–75.

Hageman R Hull C Carpenter I High functioning fragile X males. Am J Hum Genet, 1993;53:a144.

Strom CM Brusca RM Pizzi WJ . Double-blind, placebo-controlled crossover study of folinic acid (leucovorin) for the treatment of fragile X syndrome. Am J Med Genet, 1992;44:676–82.

Nolin SL Snider DA Jenkins EC Fragile X screening program in New York State. Am J Med Genet, 1991;38:251–5.

Rousseau F Rehel R Rouillard P Mutational prevalence of the fragile X premutations in 10,624 females from the general population by southern blotting. Am J Hum Genet, 1993;53:a3.

Sutherland GR Gedeon A Korman L Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N Engl J Med, 1991;325:1720–2.

Richards B Skoletsky J Shuber AP Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Human and Molecular Genetics, 1993;2:159–63.

Young ID . Diagnosing fragile X syndrome. Lancet, 1993;ii:1004–5.

Malmgren H Bondenson-Steen ML Gustavson KH Methylation and mutation patterns in the fragile X syndrome. Am J Med Genet, 1992;43:268–78.

McConkie-Rosell A Lachiewica AM Spiridigliozzi GA Evidence that methylation of the FMR-1 locus is responsible for variable phenotype expression of the fragile X syndrome. Am J Hum Genet, 1993;53:800–9.

Wald NJ . Couple screening for cystic fibrosis. Lancet, 1991;ii:1318–19.

Turner G Robinson H Laing S. Population screening for fragile X. Lancet, 1992;i:1210–13.

Cuckle HS Wald NJ . Principles of screening. In: Antenatal and neonatal screening., Oxford: Oxford University Press, 1984:1–22.

Palomaki GE Haddow JE . Population screening for fragile X syndrome. Lancet, 1993;i:373–4.

Bonthron D Strain L. Population screening for fragile-X syndrome. Lancet, 1993;ii:769–70.